Caraceni A, Zecca E, Martini C, De Conno F. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage1999; 17: 441–445.
2.
Laird MA, Gidal BE. Use of gabapentin in the treatment of neuropathic pain. Ann Pharmacother2000; 34: 802–807.
3.
Backonja MM. Anticonvulsants (antineuropathics) for neuropathic pain syndromes. Clin J Pain2000; 16(2 Suppl): S67–S72.
4.
Carter GT, Galer BS. Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am2001; 12: 447–459.
5.
Reeves AL, So EL, Sharbrough FW, Krahn LE. Movement disorders associated with the use of gabapentin. Epilepsia1996; 37: 988–990.
6.
Perucca E, Gram L, Avanzini G, Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia1998; 39: 5–17.
7.
Asconape J, Diedrich A, DellaBadia J. Myoclonus associated with the use of gabapentin. Epilepsia2000; 41: 479–481.
8.
Eckhardt K, Ammon S, Hofmann U, Riebe A, Gugeler N, Mikus G. Gabapentin enhances the analgesic effect of morphine in healthy volunteers. Anesth Analg2000; 91: 185–191.
9.
Mercadante S, Villari P, Fulfaro F. Gabapentin for opioidrelated myoclonus in cancer patients. Support Care Cancer2001; 9: 205–206.
